Bank of New York Mellon’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.23B | Sell |
12,853,368
-424,793
| -3% | -$91.4M | 0.53% | 30 |
|
|
2026
Q1 | $2.89B | Sell |
13,278,161
-221,190
| -2% | -$49.1M | 0.53% | 27 |
|
|
2025
Q4 | $3.08B | Buy |
13,499,351
+1,197,432
| +10% | +$273M | 0.54% | 23 |
|
|
2025
Q3 | $2.85B | Sell |
12,301,919
-204,578
| -2% | -$41.7M | 0.51% | 30 |
|
|
2025
Q2 | $2.32B | Sell |
12,506,497
-731,206
| -6% | -$136M | 0.44% | 37 |
|
|
2025
Q1 | $2.77B | Sell |
13,237,703
-426,197
| -3% | -$82.9M | 0.55% | 27 |
|
|
2024
Q4 | $2.43B | Sell |
13,663,900
-3,401,673
| -20% | -$625M | 0.45% | 31 |
|
|
2024
Q3 | $3.37B | Sell |
17,065,573
-463,281
| -3% | -$86.5M | 0.63% | 24 |
|
|
2024
Q2 | $3.01B | Sell |
17,528,854
-2,304,233
| -12% | -$382M | 0.57% | 24 |
|
|
2024
Q1 | $3.61B | Sell |
19,833,087
-2,271,404
| -10% | -$391M | 0.69% | 17 |
|
|
2023
Q4 | $3.43B | Buy |
22,104,491
+1,748,419
| +9% | +$255M | 0.69% | 20 |
|
|
2023
Q3 | $3.03B | Buy |
20,356,072
+352,817
| +2% | +$51.8M | 0.67% | 22 |
|
|
2023
Q2 | $2.7B | Sell |
20,003,255
-184,804
| -0.9% | -$27.1M | 0.57% | 27 |
|
|
2023
Q1 | $3.22B | Sell |
20,188,059
-54,070
| -0.3% | -$8.27M | 0.7% | 18 |
|
|
2022
Q4 | $3.27B | Sell |
20,242,129
-447,319
| -2% | -$68.6M | 0.75% | 18 |
|
|
2022
Q3 | $2.78B | Sell |
20,689,448
-598,934
| -3% | -$85.9M | 0.67% | 17 |
|
|
2022
Q2 | $3.26B | Buy |
21,288,382
+1,479,757
| +7% | +$226M | 0.75% | 14 |
|
|
2022
Q1 | $3.21B | Sell |
19,808,625
-1,576,202
| -7% | -$229M | 0.62% | 20 |
|
|
2021
Q4 | $2.9B | Buy |
21,384,827
+294,359
| +1% | +$34.8M | 0.52% | 30 |
|
|
2021
Q3 | $2.28B | Buy |
21,090,468
+94,954
| +0.5% | +$10.8M | 0.44% | 40 |
|
|
2021
Q2 | $2.36B | Buy |
20,995,514
+393,894
| +2% | +$44.4M | 0.46% | 36 |
|
|
2021
Q1 | $2.23B | Sell |
20,601,620
-161,545
| -0.8% | -$17.3M | 0.46% | 40 |
|
|
2020
Q4 | $2.22B | Sell |
20,763,165
-274,114
| -1% | -$26.3M | 0.48% | 36 |
|
|
2020
Q3 | $1.84B | Sell |
21,037,279
-350,284
| -2% | -$33M | 0.45% | 39 |
|
|
2020
Q2 | $2.1B | Buy |
21,387,563
+2,797,448
| +15% | +$246M | 0.56% | 26 |
|
|
2020
Q1 | $1.42B | Buy |
18,590,115
+3,480,190
| +23% | +$296M | 0.47% | 41 |
|
|
2019
Q4 | $1.34B | Sell |
15,109,925
-678,062
| -4% | -$56.3M | 0.34% | 61 |
|
|
2019
Q3 | $1.2B | Sell |
15,787,987
-10,746
| -0.1% | -$737K | 0.33% | 61 |
|
|
2019
Q2 | $1.15B | Sell |
15,798,733
-16,166
| -0.1% | -$1.27M | 0.31% | 67 |
|
|
2019
Q1 | $1.27B | Sell |
15,814,899
-106,534
| -0.7% | -$8.72M | 0.36% | 58 |
|
|
2018
Q4 | $1.47B | Buy |
15,921,433
+41,680
| +0.3% | +$3.67M | 0.46% | 43 |
|
|
2018
Q3 | $1.5B | Buy |
15,879,753
+382,597
| +2% | +$36.3M | 0.39% | 48 |
|
|
2018
Q2 | $1.44B | Sell |
15,497,156
-1,078,202
| -7% | -$105M | 0.39% | 49 |
|
|
2018
Q1 | $1.57B | Sell |
16,575,358
-167,259
| -1% | -$18.4M | 0.43% | 44 |
|
|
2017
Q4 | $1.62B | Sell |
16,742,617
-38,294
| -0.2% | -$3.61M | 0.43% | 43 |
|
|
2017
Q3 | $1.49B | Sell |
16,780,911
-269,637
| -2% | -$20.5M | 0.41% | 45 |
|
|
2017
Q2 | $1.24B | Sell |
17,050,548
-1,074,948
| -6% | -$72.3M | 0.35% | 59 |
|
|
2017
Q1 | $1.18B | Sell |
18,125,496
-1,078,192
| -6% | -$67.8M | 0.33% | 63 |
|
|
2016
Q4 | $1.2B | Sell |
19,203,688
-450,006
| -2% | -$27.5M | 0.35% | 55 |
|
|
2016
Q3 | $1.24B | Sell |
19,653,694
-1,287,285
| -6% | -$83.3M | 0.37% | 55 |
|
|
2016
Q2 | $1.3B | Sell |
20,940,979
-938,738
| -4% | -$57.2M | 0.4% | 51 |
|
|
2016
Q1 | $1.25B | Sell |
21,879,717
-1,821,012
| -8% | -$101M | 0.38% | 53 |
|
|
2015
Q4 | $1.4B | Sell |
23,700,729
-3,439,208
| -13% | -$198M | 0.42% | 48 |
|
|
2015
Q3 | $1.48B | Sell |
27,139,937
-2,116,957
| -7% | -$138M | 0.45% | 42 |
|
|
2015
Q2 | $1.97B | Buy |
29,256,894
+3,715,972
| +15% | +$243M | 0.54% | 31 |
|
|
2015
Q1 | $1.5B | Sell |
25,540,922
-2,226,932
| -8% | -$135M | 0.39% | 55 |
|
|
2014
Q4 | $1.82B | Sell |
27,767,854
-816,534
| -3% | -$51.5M | 0.47% | 37 |
|
|
2014
Q3 | $1.65B | Buy |
28,584,388
+2,918,871
| +11% | +$162M | 0.45% | 42 |
|
|
2014
Q2 | $1.45B | Buy |
25,665,517
+172,156
| +0.7% | +$9.03M | 0.39% | 49 |
|
|
2014
Q1 | $1.31B | Buy |
25,493,361
+753,520
| +3% | +$38.1M | 0.36% | 54 |
|
|
2013
Q4 | $1.31B | Sell |
24,739,841
-1,433,136
| -5% | -$70.4M | 0.36% | 51 |
|
|
2013
Q3 | $1.17B | Buy |
26,172,977
+2,526,151
| +11% | +$112M | 0.35% | 52 |
|
|
2013
Q2 | $978M | Buy |
+23,646,826
| New | +$1.03B | 0.31% | 64 |
|
Other funds holding ABBV
Bank of New York Mellon's ABBV Position: Q2 2026 in Review
Bank of New York Mellon reduced its AbbVie (ABBV) stake by 3.2% in Q2 2026, selling an estimated $91.4M and leaving 12,853,368 shares worth $3.23B. The position accounts for 0.53% of the portfolio, ranked #30.
Bank of New York Mellon first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.61B in Q1 2024. 3,387 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Bank of New York Mellon held 12,853,368 shares of AbbVie worth $3.23B as of Q2 2026.
- Bank of New York Mellon sold 424,793 AbbVie shares in Q2 2026, an estimated $91.4M.
- AbbVie made up 0.53% of Bank of New York Mellon's portfolio in Q2 2026, its #30 holding.
- Bank of New York Mellon first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's AbbVie position peaked at $3.61B in Q1 2024.
- 3,387 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.